BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schneider EH, Neumann D, Seifert R. Histamine H4-receptor expression in the brain? Naunyn-Schmiedeberg's Arch Pharmacol 2015;388:5-9. [DOI: 10.1007/s00210-014-1067-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Seifert R. Naunyn-Schmiedeberg's Archives of Pharmacology under new editorship: change and continuity. Naunyn Schmiedebergs Arch Pharmacol 2016;389:667-70. [PMID: 27222234 DOI: 10.1007/s00210-016-1261-3] [Reference Citation Analysis]
2 Zhou P, Homberg JR, Fang Q, Wang J, Li W, Meng X, Shen J, Luan Y, Liao P, Swaab DF, Shan L, Liu C. Histamine-4 receptor antagonist JNJ7777120 inhibits pro-inflammatory microglia and prevents the progression of Parkinson-like pathology and behaviour in a rat model. Brain Behav Immun 2019;76:61-73. [PMID: 30408497 DOI: 10.1016/j.bbi.2018.11.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
3 Wágner G, Mocking TAM, Arimont M, Provensi G, Rani B, Silva-Marques B, Latacz G, Da Costa Pereira D, Karatzidou C, Vischer HF, Wijtmans M, Kieć-Kononowicz K, de Esch IJP, Leurs R. 4-(3-Aminoazetidin-1-yl)pyrimidin-2-amines as High-Affinity Non-imidazole Histamine H3 Receptor Agonists with in Vivo Central Nervous System Activity. J Med Chem 2019;62:10848-66. [PMID: 31675226 DOI: 10.1021/acs.jmedchem.9b01462] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Petri D, Schlicker E. A search for presynaptic inhibitory histamine receptors in guinea-pig tissues: Further H3 receptors but no evidence for H4 receptors. Neuropharmacology 2016;106:129-34. [PMID: 26211976 DOI: 10.1016/j.neuropharm.2015.06.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
5 Schneider EH, Seifert R. The histamine H4-receptor and the central and peripheral nervous system: A critical analysis of the literature. Neuropharmacology 2016;106:116-28. [PMID: 25986697 DOI: 10.1016/j.neuropharm.2015.05.004] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 7.4] [Reference Citation Analysis]
6 Sharma A, Muresanu DF, Patnaik R, Menon PK, Tian ZR, Sahib S, Castellani RJ, Nozari A, Lafuente JV, Buzoianu AD, Skaper SD, Bryukhovetskiy I, Manzhulo I, Wiklund L, Sharma HS. Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy. Prog Brain Res 2021;266:1-73. [PMID: 34689857 DOI: 10.1016/bs.pbr.2021.06.003] [Reference Citation Analysis]
7 Schneider EH. Microglial histamine H4R in the pathophysiology of Parkinson’s disease—a new actor on the stage? Naunyn-Schmiedeberg's Arch Pharmacol 2019;392:641-5. [DOI: 10.1007/s00210-019-01635-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Bartole E, Grätz L, Littmann T, Wifling D, Seibel U, Buschauer A, Bernhardt G. UR-DEBa242: A Py-5-Labeled Fluorescent Multipurpose Probe for Investigations on the Histamine H 3 and H 4 Receptors. J Med Chem 2020;63:5297-311. [DOI: 10.1021/acs.jmedchem.0c00160] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Adami M, Micheloni C, Grandi D, Stark H. Differential effects of functionally different histamine H4 receptor ligands on acute irritant dermatitis in mice. Naunyn Schmiedebergs Arch Pharmacol 2018;391:1387-97. [PMID: 30145688 DOI: 10.1007/s00210-018-1553-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Gergs U, Jung F, Buchwalow IB, Hofmann B, Simm A, Treede H, Neumann J. Pharmacological and physiological assessment of serotonin formation and degradation in isolated preparations from mouse and human hearts. American Journal of Physiology-Heart and Circulatory Physiology 2017;313:H1087-97. [DOI: 10.1152/ajpheart.00350.2017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
11 Geyer R, Nordemann U, Strasser A, Wittmann HJ, Buschauer A. Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists. J Med Chem 2016;59:3452-70. [PMID: 27007611 DOI: 10.1021/acs.jmedchem.6b00120] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]